The effect of 17 beta-estradiol on maternal immune activation-induced changes in prepulse inhibition and dopamine receptor and transporter binding in female rats
Alyssa Sbisa, Snezana Kusljic, Damon Zethoven, Maarten van den Buuse, Andrea Gogos
Schizophrenia Research | ELSEVIER | Published : 2020
Maternal immune activation (MIA) during pregnancy is associated with an increased risk of development of schizophrenia in later life. 17β-estradiol treatment may improve schizophrenia symptoms, but little is known about its efficacy on MIA-induced psychosis-like behavioural deficits in animals. Therefore, in this study we used the poly(I:C) neurodevelopmental model of schizophrenia to examine whether MIA-induced psychosis-like behavioural and neurochemical changes can be attenuated by chronic treatment (2-6 weeks) with 17β-estradiol. Pregnant rats were treated with saline or the viral mimetic, poly(I:C), on gestational day 15 and adult female offspring were tested for changes in prepulse inh..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council of Australia
AG is supported by a Career Development Fellowship from the National Health and Medical Research Council of Australia (ID 1108098). The authors gratefully acknowledge the financial support of the Jared Purton Foundation and the One-in-Five Foundation. The Florey Institute of Neuroscience and Mental Health acknowledges the support from the Victorian Government's Operational Infrastructure Support Grant.